LENZ Therapeutics Inc. (LENZ) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LENZ Therapeutics Inc.

    NASDAQ: LENZ · Real-Time Price · USD
    39.63
    -2.35 (-5.60%)
    At close: Sep 08, 2025, 3:59 PM
    40.59
    2.42%
    After-hours: Sep 08, 2025, 06:39 PM EDT

    LENZ Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -12.34 -0.81 -1.22 -6.89
    PEG Ratio
    		 0.15 -0.04 -0.02 -1.9
    PS Ratio
    		 n/a n/a 8.21 n/a
    PB Ratio
    		 3.01 0.55 0.42 1.25
    P/FCF Ratio
    		 -10.26 -1.67 -1.3 -8.32
    P/OCF Ratio
    		 -10.34 -1.67 -1.4 -9.22
    OCF/S Ratio
    		 n/a n/a -5.87 n/a
    Debt / Equity Ratio
    		 0.01 0.00 0.02 n/a
    Quick Ratio
    		 20.36 39.20 21.11 31.44
    Current Ratio
    		 20.36 39.20 21.11 31.44
    Asset Turnover
    		 n/a n/a 0.05 n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.24 -0.68 -0.34 -0.18
    Return on Assets
    		 -0.23 -0.66 -0.31 -0.18
    Return on Invested Capital
    		 -0.29 -0.39 -0.34 -0.16
    Dividend Yield
    		 0.50 n/a n/a n/a
    Payout Ratio
    		 -6.17 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a 0.44 n/a
    Net Profit Margin
    		 n/a n/a -6.74 n/a
    Pretax Profit Margin
    		 n/a n/a -6.74 n/a
    Operating Profit Margin
    		 n/a n/a -7.04 n/a
    FCF Margin
    		 n/a n/a -6.3 n/a
    EBITDA Margin
    		 n/a n/a -6.49 n/a

    Add to Watchlist